GPT and metabolic dysfunction-associated steatotic liver disease: Most used ultrasound to detect NAFLD [31,32,35,36,37,38,39,41,42,44,47,48], with some relying on serum alanine transaminase (ALT) as a biomarker to detect ‘suspected NAFLD’ [40,45,46].